St John's wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist.

St. John's wort is an herb commonly used in Europe for decades and more recently the topic of scientific investigation in this country. St. John's wort has been found more effective than placebo and equally as effective as tricyclic antidepressants in the short-term management of mild-to-moderate depression. Comparisons to selective serotonin reuptake inhibitors have provided equivocal data. While it is generally well tolerated in clinical use, there is accumulating evidence of significant interactions with drugs. This evidence-based presentation of the literature includes a brief description of pharmacodynamics and clinical applications, followed by a systematic review of adverse effects, toxicity, and drug interactions.

[1]  W. Kirch,et al.  Unwanted pregnancy on self-medication with St John's wort despite hormonal contraception. , 2008, British journal of clinical pharmacology.

[2]  Eric Plotnick Research abstracts , 2003 .

[3]  P. Oakeshott,et al.  Interactions of the oral contraceptive pill with antibiotics and St John's work: knowledge of female college students. , 2002, Family practice.

[4]  R. Robinson,et al.  Hypertensive crisis associated with St. John's Wort. , 2002, The American journal of medicine.

[5]  Norma Pugh,et al.  Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. , 2002, JAMA.

[6]  S. Crowe,et al.  Delayed emergence and St. John's wort. , 2002, Anesthesiology.

[7]  D. Menkes,et al.  St. John's wort extract induces CYP3A and CYP2E1 in the Swiss Webster mouse. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  J. Brockmöller,et al.  Decreased Plasma Levels of Amitriptyline and Its Metabolites on Comedication With an Extract From St. John’s Wort (Hypericum perforatum) , 2002, Journal of clinical psychopharmacology.

[9]  I. Schweitzer,et al.  A Case of Mania Induced by Hyperlcum , 2002, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[10]  M. Spinella,et al.  Hypomania induced by herbal and pharmaceutical psychotropic medicines following mild traumatic brain injury , 2002, Brain injury.

[11]  K. M. Lin,et al.  An open trial of nifedipine-herb interactions Nifedipine with St Johns wort, Ginseng or Ginkgo biloba , 2001 .

[12]  A. Fujimura,et al.  Different effects of St John's Wort on the pharmacokinetics of simvastatin and pravastatin , 2001, Clinical pharmacology and therapeutics.

[13]  M. Levine,et al.  Evaluation of the Association Between St. John's Wort and Elevated Thyroid‐Stimulating Hormone , 2001, Pharmacotherapy.

[14]  D. Kroll,et al.  Catalytic inhibition of human DNA topoisomerase IIalpha by hypericin, a naphthodianthrone from St. John's wort (Hypericum perforatum). , 2001, Biochemical pharmacology.

[15]  B. Jaber,et al.  Interaction between cyclosporine and Hypericum perforatum (St. John's wort) after organ transplantation. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  W. Scholte,et al.  [Mania during the use of a combination preparation with St. John's wort (Hypericum perforatum)]. , 2001, Nederlands tijdschrift voor geneeskunde.

[17]  J. Cott,et al.  Herb-Drug Interactions: Focus on Pharmacokinetics , 2001, CNS Spectrums.

[18]  T. Kaptchuk,et al.  Perceptions about Complementary Therapies Relative to Conventional Therapies among Adults Who Use Both: Results from a National Survey , 2001, Annals of Internal Medicine.

[19]  N. Banner,et al.  Low cyclosporin-A level due to Saint-John's-wort in heart transplant patients. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  T. Baghai,et al.  Neuroendocrine Effects of Hypericum Extract WS 5570 in 12 Healthy Male Volunteers , 2001, Pharmacopsychiatry.

[21]  B. Gurley,et al.  St John's Wort: A Hidden Risk for Transplant Patients , 2001, Progress in transplantation.

[22]  J. Bhopal,et al.  St John's Wort-Induced Sexual Dysfunction , 2001, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[23]  J. Drewe,et al.  [St. John's wort: a pharmaceutical with potentially dangerous interactions]. , 2001, Praxis.

[24]  D. Ladner,et al.  Synergistic toxicity of δ‐aminolaevulinic acid‐induced protoporphyrin IX used for photodiagnosis and hypericum extract, a herbal antidepressant , 2001, The British journal of dermatology.

[25]  J. Schulte‐Mönting,et al.  Single-dose and steady-state administration of Hypericum perforatum extract (St John's Wort) does not influence skin sensitivity to UV radiation, visible light, and solar-simulated radiation. , 2001, Archives of dermatology.

[26]  F. Squadrito,et al.  Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum. , 2001, Pharmacopsychiatry.

[27]  J. Beijnen,et al.  Drug interaction between St John's wort and nevirapine. , 2001, AIDS.

[28]  M. Seeman,et al.  Adverse Reactions to St John's Wort , 2001, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[29]  A. Prince,et al.  Pharmacokinetics, Safety, and Antiviral Effects of Hypericin, a Derivative of St. John's Wort Plant, in Patients with Chronic Hepatitis C Virus Infection , 2001, Antimicrobial Agents and Chemotherapy.

[30]  B. Gurley,et al.  HERBAL SUPPLEMENTS: A POTENTIAL FOR DRUG INTERACTIONS IN TRANSPLANT RECIPIENTS , 2001, Transplantation.

[31]  J. Greeson,et al.  St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature , 2001, Psychopharmacology.

[32]  L. Miller Drug Interactions Known or Potentially Associated with St. John’s Wort , 2001 .

[33]  P. Nathan Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology , 2001, Journal of psychopharmacology.

[34]  R. Laird,et al.  Psychotic Episode During Use of St. John's Wort , 2001 .

[35]  V. Schulz [Incidence and clinical relevance of interactions and side-effects of hypericum preparations]. , 2000, Praxis.

[36]  S. Piscitelli,et al.  Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers , 2000, Clinical pharmacology and therapeutics.

[37]  P. Meier,et al.  St John's Wort induces intestinal P‐glycoprotein/MDR1 and intestinal and hepatic CYP3A4 , 2000, Clinical pharmacology and therapeutics.

[38]  G. Gerken,et al.  Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation. , 2000, Journal of hepatology.

[39]  D. Roberts,et al.  Erythroderma associated with St John’s wort , 2000, The British journal of dermatology.

[40]  K. Budde,et al.  Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin. , 2000, International journal of clinical pharmacology and therapeutics.

[41]  P. Assalian Sildenafil for St. John Wort–Induced Sexual Dysfunction , 2000, Journal of sex & marital therapy.

[42]  J. Sprung,et al.  A possible cause of cardiovascular collapse during anesthesia: long-term use of St. John's Wort. , 2000, Journal of clinical anesthesia.

[43]  L. Taylor,et al.  An open-label trial of St. John's Wort (Hypericum perforatum) in obsessive-compulsive disorder. , 2000, The Journal of clinical psychiatry.

[44]  S. Lal,et al.  St. John's wort and schizophrenia. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[45]  W. Müller,et al.  Inhibition of Synaptosomal Uptake of 3H-L-glutamate and 3H-GABA by Hyperforin, a Major Constituent of St. John's Wort: The Role of Amiloride Sensitive Sodium Conductive Pathways , 2000, Neuropsychopharmacology.

[46]  R. Obach,et al.  Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. , 2000, The Journal of pharmacology and experimental therapeutics.

[47]  J. Arnason,et al.  An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. , 2000, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[48]  L. Moore,et al.  St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[49]  T. Breidenbach,et al.  Profound drop of cyclosporin A whole blood trough levels caused by St. John's wort (Hypericum perforatum) , 2000, Transplantation.

[50]  R. Sommi,et al.  Consumer Use of St. John's Wort: A Survey on Effectiveness, Safety, and Tolerability , 2000, Pharmacotherapy.

[51]  E. Kantor,et al.  PHARMACOKINETICS AND DRUG DISPOSITION St John’s Wort: Effect on CYP3A4 activity , 2000 .

[52]  Dr. Peter H. Yu Effect of the Hypericum Perforatum Extract on Serotonin Turnover in the Mouse Brain , 2000, Pharmacopsychiatry.

[53]  E. Schrader Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mildmoderate depression , 2000, International clinical psychopharmacology.

[54]  T. M. Brown Acute St. John's wort toxicity. , 2000, The American journal of emergency medicine.

[55]  M. Lane-Brown Photosensitivity associated with herbal preparations off St John's wort (Hypericum perforatum) , 2000, The Medical journal of Australia.

[56]  F. Ruschitzka,et al.  Acute heart transplant rejection due to Saint John's wort , 2000, The Lancet.

[57]  J. Falloon,et al.  Indinavir concentrations and St John's wort , 2000, The Lancet.

[58]  Q. Yue,et al.  Safety of St John's wort (Hypericum perforatum) , 2000, The Lancet.

[59]  A. Mallinger,et al.  St. John's Wort: three cases of possible mania induction. , 2000, Journal of clinical psychopharmacology.

[60]  B. Gaster,et al.  St John's wort for depression: a systematic review. , 2000, Archives of internal medicine.

[61]  S. Risch,et al.  Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers. , 2000, Life sciences.

[62]  A. Fugh-Berman Herb-drug interactions , 2000, The Lancet.

[63]  L. S. Koupparis Harmless herbs: a cause for concern? , 2000, Anaesthesia.

[64]  E. Esposito,et al.  Effect of Acute Administration of Hypericum Perforatum-CO2 Extract on Dopamine and Serotonin Release in the Rat Central Nervous System , 2000, Pharmacopsychiatry.

[65]  C. Bench,et al.  Mania in a patient receiving testosterone replacement post-orchidectomy taking St John’s wort and sertraline , 2000, Journal of psychopharmacology.

[66]  A. Nierenberg,et al.  Mania associated with St. John’s wort , 1999, Biological Psychiatry.

[67]  I. Roots,et al.  Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum) , 1999, Clinical pharmacology and therapeutics.

[68]  J. Streltzer,et al.  St. John's wort for depression: a meta-analysis of well-defined clinical trials. , 1999, The Journal of nervous and mental disease.

[69]  S. Lippmann,et al.  Herbal medicines as a factor in delirium. , 1999, Psychiatric services.

[70]  J. Simon,et al.  Antibacterial activity of hyperforin from St John's wort, against multiresistant Staphylococcus aureus and gram-positive bacteria , 1999, The Lancet.

[71]  V. Giambanco,et al.  St. John's Wort and Antidepressant Drug Interactions in the Elderly , 1999, Journal of geriatric psychiatry and neurology.

[72]  H. Taguchi,et al.  Pentamidine-Induced Hemolytic Anemia in an AIDS Patient , 1999, The Annals of pharmacotherapy.

[73]  D. Kroll,et al.  Potential Metabolic Interaction between St. John's Wort and Theophylline , 1999, The Annals of pharmacotherapy.

[74]  W. Patton,et al.  Inhibition of Human Sperm Motility by Specific Herbs Used in Alternative Medicine , 1999, Journal of Assisted Reproduction and Genetics.

[75]  R. Kaufmann,et al.  Phototoxic effects of Hypericum extract in cultures of human keratinocytes compared with those of psoralen. , 1999, Photochemistry and photobiology.

[76]  R. Kaufmann,et al.  Phototoxic Effects of Hypericum Extract in Cultures of Human Keratinocytes Compared with Those of Psoralen , 1999 .

[77]  J. Neary,et al.  Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes , 1999, Brain Research.

[78]  C. Schneck St. John's wort and hypomania. , 1998, The Journal of clinical psychiatry.

[79]  R. Kessler,et al.  Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. , 1998, JAMA.

[80]  L. Cohen,et al.  St John's wort during pregnancy. , 1998, JAMA.

[81]  V. Zlotnik,et al.  Neuropharmacology of St. John's Wort (Hypericum) , 1998, The Annals of pharmacotherapy.

[82]  G. Bove Acute neuropathy after exposure to sun in a patient treated with St John's Wort , 1998, The Lancet.

[83]  E. Ernst,et al.  Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.) , 1998, European Journal of Clinical Pharmacology.

[84]  S S Chatterjee,et al.  Activity profiles of two hyperforin-containing hypericum extracts in behavioral models. , 1998, Pharmacopsychiatry.

[85]  S. Chatterjee,et al.  Oral Bioavailability of Hyperforin from Hypericum Extracts in Rats and Human Volunteers , 1998, Pharmacopsychiatry.

[86]  B. Meier,et al.  Hypericum treatment of mild–moderate depression in a placebo–controlled study. A prospective, double–blind, randomized, placebo–controlled, multicentre study , 1998 .

[87]  R. Raffa Screen of receptor and uptake-site activity of hypericin component of St. John's wort reveals sigma receptor binding. , 1998, Life sciences.

[88]  J. Gordon SSRIs and St.John's Wort: possible toxicity? , 1998, American family physician.

[89]  Miller Al St. John's Wort (Hypericum perforatum): clinical effects on depression and other conditions. , 1998 .

[90]  M. Hazzard Klaus Linde, Gilbert Ramirez, Cynthia D. Mulrow, Andrej Pauls, Wolfgang Weidenhammer, and Dieter Melchart. (1996). St. John's wort for depression—An overview and meta-analysis of randomized clinical trials. British Medical Journal, 313, 3 August 1996, 253-8 , 1997 .

[91]  J. Gleitz,et al.  Effects of Long-Term Administration of Hypericum Extracts on the Affinity and Density of the Central Serotonergic 5-HT1 A and 5-HT2 A Receptors , 1997, Pharmacopsychiatry.

[92]  A. Nahrstedt,et al.  Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity. , 1997, Pharmacopsychiatry.

[93]  J. Brockmöller,et al.  Hypericin and Pseudohypericin: Pharmacokinetics and Effects on Photosensitivity in Humans , 1997, Pharmacopsychiatry.

[94]  V. Eu,et al.  Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10. , 1997 .

[95]  U. Hafner,et al.  Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity. , 1997, Pharmacopsychiatry.

[96]  S. Kasper,et al.  Treatment of Seasonal Affective Disorder (SAD) with Hypericum Extract , 1997, Pharmacopsychiatry.

[97]  J. Czekalla,et al.  The effect of hypericum extract on cardiac conduction as seen in the electrocardiogram compared to that of imipramine. , 1997, Pharmacopsychiatry.

[98]  J. Cott In Vitro Receptor Binding and Enzyme Inhibition by Hypericum perforatum Extract , 1997, Pharmacopsychiatry.

[99]  A. Nahrstedt,et al.  Biologically Active and Other Chemical Constituents of the Herb of Hypericum perforatum L. , 1997, Pharmacopsychiatry.

[100]  J. Ring,et al.  Reversible Erhöhung der Photosensitivität im UV-B-Bereich durch Johanniskrautextrakt- Präparate , 1997, Der Hautarzt.

[101]  J. Brockmöller,et al.  Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin , 1996, Antimicrobial agents and chemotherapy.

[102]  C. Mulrow,et al.  St John's wort for depression—an overview and meta-analysis of randomised clinical trials , 1996, BMJ.

[103]  J. Brockmöller,et al.  Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers. , 1994, Journal of geriatric psychiatry and neurology.

[104]  H. Woelk,et al.  Benefits and risks of the hypericum extract LI 160: drug monitoring study with 3250 patients. , 1994, Journal of geriatric psychiatry and neurology.

[105]  H M Thiede,et al.  Inhibition of MAO and COMT by hypericum extracts and hypericin. , 1994, Journal of geriatric psychiatry and neurology.

[106]  H. Wagner,et al.  Inhibition of MAO by Fractions and Constituents of Hypericum Extract , 1994, Journal of geriatric psychiatry and neurology.

[107]  M. Ploch,et al.  Modulation of Cytokine Expression by Hypericum Extract , 1994, Journal of geriatric psychiatry and neurology.

[108]  J. Mortimer,et al.  Cognitive Performance Test: A New Approach to Functional Assessment in Alzheimer's Disease , 1994 .

[109]  J. Hölzl,et al.  Pharmacokinetic Test of [14 C]-Labelled Hypericin and Pseudohypericin from Hypericum perforatum and Serum Kinetics of Hypericin in Man , 1991 .

[110]  S. Okpanyi,et al.  [Genotoxicity of a standardized Hypericum extract]. , 1990, Arzneimittel-Forschung.

[111]  O. Schimmer,et al.  The mutagenic potencies of plant extracts containing quercetin in Salmonella typhimurium TA98 and TA100. , 1988, Mutation research.

[112]  H. Wagner,et al.  Inhibition of Monoamine Oxidase by Hypercin , 1984 .

[113]  C. Klier,et al.  St. John's wort (Hypericum perforatum)--is it safe during breastfeeding? , 2002, Pharmacopsychiatry.

[114]  J. D. Stewart,et al.  Effect of prenatally administered hypericum (St John's wort) on growth and physical maturation of mouse offspring. , 2001, American journal of obstetrics and gynecology.

[115]  C. Mulrow,et al.  St John's wort for depression. , 2000, The Cochrane database of systematic reviews.

[116]  T. Breidenbach,et al.  Drug interaction of St John's wort with cyclosporin. , 2000, Lancet.

[117]  D. Wheatley,et al.  Hypericum in seasonal affective disorder (SAD). , 1999, Current medical research and opinion.

[118]  M. Groves Hypericum perforatum L. , 1998 .

[119]  J. Cott NCDEU update. Natural product formulations available in europe for psychotropic indications. , 1995, Psychopharmacology bulletin.

[120]  E. Ford,et al.  An investigation of the type of photosensitization caused by the ingestion of St John's Wort (Hypericum perforatum) by calves. , 1981, Journal of comparative pathology.